E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis
1997

E-cadherin Inactivation in Lobular Carcinoma in Situ of the Breast

Sample size: 156 publication Evidence: moderate

Author Information

Author(s): CBJ Vos, AM Cleton-Jansen, G Berx, WJF de Leeuw, NT ter Haar, F van Roy, CJ Cornelisse, JL Peterse, MJ van de Vijver

Primary Institution: Leiden University Medical Centre

Hypothesis

E-cadherin inactivation plays a crucial role in the development of lobular breast carcinoma.

Conclusion

E-cadherin is inactivated in lobular carcinoma in situ, indicating it is an early event in breast cancer development.

Supporting Evidence

  • E-cadherin expression was absent in all six cases of lobular carcinoma in situ.
  • All 150 cases of ductal carcinoma in situ showed clear E-cadherin expression.
  • Identical mutations and loss of heterozygosity were found in both lobular carcinoma in situ and adjacent invasive lobular carcinoma.

Takeaway

This study found that a protein called E-cadherin is missing in certain early forms of breast cancer, which might help us understand how these cancers start.

Methodology

The study analyzed E-cadherin expression and mutations in 156 cases of in situ carcinoma, including 150 ductal carcinoma in situ and 6 lobular carcinoma in situ.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication